Axel Schwan (QSR) receives new share unit grants and holds large option stake
Rhea-AI Filing Summary
Restaurant Brands International executive Axel Schwan, President of Tim Hortons US & Canada, reported multiple equity compensation awards rather than market trades. On April 2, 2026, he received several grants of restricted share units and performance share units, each convertible into an equal number of common shares.
Key awards include 492.1585, 550.7587 and 767.2684 performance share units that have performance periods running into 2027, 2028 and 2029 and, if earned, vest in March of those years. Following these awards, he also directly holds 197,481.9293 common shares and fully vested stock options over 40,000, 30,000 and 56,000 shares at exercise prices between $58.44 and $66.31.
Positive
- None.
Negative
- None.
Insights
Routine equity grants increase Schwan’s long-term QSR exposure without any share sales.
The Form 4 shows Axel Schwan receiving several grants of restricted and performance share units in 2026, all at a nominal grant price of $0.00. These are compensation awards, not open‑market purchases or sales, so they carry limited short‑term trading signal.
Performance share units of 492.1585, 550.7587 and 767.2684 units have performance periods ending on February 23, 2027, February 28, 2028 and February 25, 2029, with potential vesting on March 15, 2027, March 15, 2028 and March 15, 2029. Actual shares earned will vary with performance against stated conditions.
Schwan also holds fully vested options over 40,000, 30,000 and 56,000 common shares at exercise prices of $58.44, $64.75 and $66.31, expiring between 2028 and 2030. These positions, together with 197,481.9293 common shares held directly, indicate substantial ongoing equity exposure but no disposition in this filing.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Restricted Share Units | 37.518 | $0.00 | -- |
| Grant/Award | Restricted Share Units | 61.956 | $0.00 | -- |
| Grant/Award | Performance Share Units | 492.159 | $0.00 | -- |
| Grant/Award | Restricted Share Units | 81.332 | $0.00 | -- |
| Grant/Award | Performance Share Units | 550.759 | $0.00 | -- |
| Grant/Award | Restricted Share Units | 97.301 | $0.00 | -- |
| Grant/Award | Performance Share Units | 767.268 | $0.00 | -- |
| holding | Option (Right to Buy) | -- | -- | -- |
| holding | Option (Right to Buy) | -- | -- | -- |
| holding | Option (Right to Buy) | -- | -- | -- |
| holding | Common Shares | -- | -- | -- |
Footnotes (1)
- These options are fully vested and exercisable. Each restricted share unit represents a contingent right to receive one common share. Represents dividend equivalent rights that accrued on the underlying award of restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate. These restricted share units vest in equal annual installments. The remaining vesting will occur on December 15, 2026. These restricted share units vest in equal annual installments. The remaining vestings will occur on December 15, 2026 and December 15, 2027. The shares reported represent an award of performance based restricted share units ("2024 PBRSUs") granted to the Reporting Person. The 2024 PBRSUs will have a performance period beginning February 23, 2024 and ending February 23, 2027 and to the extent earned will vest on March 15, 2027. The number of common shares that will be earned at the end of the performance period is subject to increase or decrease based on the results of the performance condition. Represents dividend equivalent rights that accrued on the underlying award of performance based restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable performance based restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the performance based restricted share units to which they relate. These restricted share units vest in equal annual installments. The remaining vestings will occur on December 15, 2026, December 15, 2027 and December 15, 2028. The shares reported represent an award of performance based restricted share units ("2025 PBRSUs") granted to the Reporting Person. The 2025 PBRSUs will have a performance period beginning February 28, 2025 and ending February 28, 2028 and to the extent earned will vest on March 15, 2028. The number of common shares that will be earned at the end of the performance period is subject to increase or decrease based on the results of the performance condition. These restricted share units vest in equal annual installments. The vestings will occur on December 15, 2026, December 15, 2027, December 15, 2028 and December 15, 2029. The shares reported represent an award of performance based restricted shares units ("2026 PBRSUs") granted to the Reporting Person. The 2026 PBRSUs will have a performance period beginning February 25, 2026 and ending February 25, 2029 and to the extent earned will vest on March 15, 2029. The number of common shares that will be earned at the end of the performance period is subject to increase or decrease based on the results of the performance condition.